WhatsApp Skip to main content

Dr. Harsh J Shah

When Imatinib Stops Working: What Comes Next for GIST

Last updated: 17-Nov-2026

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah, stomach cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Stomach Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

Most advanced GISTs slowly learn to beat imatinib. When that happens, other tablets come next in a set order: sunitinib, then regorafenib, then ripretinib.

First check whether one spot is growing or many. One growing spot can often be removed or burned while the same tablet carries on.

Never stop the tablet on your own. A GIST can regrow fast when the drug is paused, so every change should be planned.

For the whole story of GIST, from the first test to imatinib and surgery, read our GIST treatment in Ahmedabad page. This post covers what happens when imatinib stops working.

What does "imatinib has stopped working" mean?

It means the scan shows the tumour growing even though you take the tablet every day. It is called resistance, and it comes in two kinds.

  • Early resistance. The tumour never really shrank, and it grew within the first six months. This points to the first gene change in the tumour, which imatinib cannot block. The gene report is checked again.
  • Later resistance. The tumour shrank or stayed still for a long time, then began to grow. A new gene change has appeared inside it. This is the usual kind.

Before anyone calls it failure, the scans are read with care. A responding tumour can look bigger on a scan when it is filling with fluid or bleeding inside, while it is actually dying. Doctors compare the density of the tumour as well as its size. Sometimes a second look or a different scan settles it. How the original gene result decides the first tablet is explained in our post on what your GIST gene report means.

Is one spot growing, or many?

This single question changes the plan. One spot growing while the rest stays quiet is a local problem. Many spots growing together is a drug problem.

  • One growing spot means one small group of cells has become resistant. The rest of the tumour still answers to imatinib.
  • Such a spot can often be removed by an operation, burned with a needle, or treated with focused radiation, while the tablet continues.
  • Changing the drug for a single spot uses up an option that you may need later.
  • Many growing spots, or new spots in several places, mean several resistant groups. Then the drug has to change.

This is where a surgeon sits with the medical oncologist. Dr Shah looks at whether the spot is safe to remove, what it would cost you in function, and whether it is the right moment. The role of surgery alongside tablets is also covered in our post on how surgery and imatinib are put in order.

Can a higher imatinib dose help first?

Sometimes. If you have been on the usual dose and the tumour carries the most common gene change, a higher dose can win some more time before you switch.

  • The usual dose is 400 mg a day. The higher dose is 800 mg a day, taken in two parts.
  • In studies, a fair number of people who grew on the usual dose held steady for a while on the higher one, although the gain was short.
  • People whose tumour carries the other common KIT change usually start on the higher dose already, so there is nothing left to raise.
  • The higher dose brings more swelling, tiredness and nausea. If it is hard to tolerate, the next tablet is started instead.

What is tried after imatinib, and in what order?

The order is fixed by the trials that proved each drug. After imatinib comes sunitinib, then regorafenib, then ripretinib. A few people need a different drug from the start.

The usual order of GIST tablets after imatinib
StepDrugWhy it is used here
SecondSunitinibProved to slow growth after imatinib. Works well against some of the gene changes that cause resistance.
ThirdRegorafenibSlowed growth when imatinib and sunitinib had both failed. Covers some changes that sunitinib misses.
FourthRipretinibSlowed growth after three earlier drugs. Works across many gene changes and is gentler on the body.
Special caseAvapritinibMeant for one rare gene change, PDGFRA D842V, which imatinib cannot touch.
Late optionsTrial drugs, imatinib again, local treatment for comfortUsed when the standard steps are used up or out of reach.

Ripretinib was also tested as a second step against sunitinib and did not beat it, so sunitinib stays second. Avapritinib was tested against regorafenib in people without the D842V change and did not win either, so it is not used outside that change. The studies are set out in plain words in our post on the key GIST studies and what is new.

What should you know about sunitinib?

Sunitinib is the usual second tablet. It works, but it brings tiredness, sore hands and feet, high blood pressure and a slow thyroid, all of which can be watched for and treated.

  • It was first given for four weeks on and two weeks off. Many people now take a lower dose every day without a break, which is easier to follow and works about as well.
  • The off weeks can bring a rush of pain or swelling in some patients, which is one reason the daily plan is liked.
  • Blood pressure is checked at home each week in the first cycle. A tablet is added if it rises.
  • A thyroid test is done before the start and every few months. A slow thyroid causes a large share of the “drug tiredness” people report, and a thyroid tablet fixes it.
  • Skin and hair may turn yellowish. This is harmless and goes back after the drug stops.

What about regorafenib and ripretinib?

Regorafenib is hard on the hands and feet, and the skin care starts before the first tablet. Ripretinib is easier to take but costs far more.

  • Regorafenib. Taken for three weeks, then one week off. The commonest problem is a sore, peeling skin on palms and soles. Soft footwear, a daily urea cream from day one and removal of hard skin before starting prevent most of it. The dose is lowered early rather than late.
  • Ripretinib. One tablet a day. Hair thinning, tiredness, muscle ache and a rise in blood pressure are the usual effects. Rarely, a skin growth appears and is simply removed.
  • Both drugs can raise the risk of bleeding, so ulcers, varices and old bleeding spots are looked for first.

What if the gene change is PDGFRA D842V?

A small group of GISTs carry this change. Imatinib does not work on them from the start, and avapritinib is the drug made for them.

  • It is used as the first drug in this group, instead of imatinib.
  • In the main study, most of these tumours shrank, and the response lasted for a long time.
  • Its special side effect is memory and thinking trouble. It comes on slowly over weeks to months and often eases when the dose is lowered. Families should be told about it before the start.
  • There is also a rare risk of bleeding inside the head, so anyone who has had one is not given it.

Should the gene test be repeated?

When the tumour grows on treatment, a repeat test shows what has changed. It helps choose the next drug and the next trial, and is worth doing where it is available.

  • A piece of the growing spot can be tested if it is safe to take a biopsy.
  • A blood test can pick up traces of the tumour’s genes from several spots at once, without a needle in the tumour.
  • Different spots can carry different changes, so one sample may miss some.
  • If a growing spot is removed, it is worth sending several labelled pieces to the laboratory.

Why must the tablet never be paused on your own?

Because a GIST can regrow quickly when the drug is paused. A trial that stopped imatinib in people with a stable tumour saw fast progress in most of them.

  1. Ask your oncologist before you skip a dose for a holiday, a wedding or a procedure.
  2. For surgery, the tablet is usually stopped only a day or two before the operation and restarted within a few days after.
  3. If side effects are bad, call at once. A lower dose or a rest of a few days is planned, not left to guesswork.
  4. If the drug is too costly to continue, say so early. A cheaper generic, a support programme or another plan can be arranged.

What does treatment cost in India?

Imatinib and sunitinib are made by Indian companies as generics and are within reach of many families. Ripretinib and avapritinib are costly and hard to get.

  • Regorafenib generics now exist and bring the third step closer.
  • For ripretinib and avapritinib, the ways in are company access programmes, trials at large cancer centres, and some state insurance schemes after approval.
  • Imatinib taken again after other drugs have failed gave a small but real gain in one study. It is cheap, and it is used for comfort when nothing else is open.
  • Ask for the plan on paper, with the cost of each step, before you begin it.

Frequently asked questions

What does it mean when GIST grows on imatinib?

The tumour has found a way around the drug, usually through a new gene change. The scan is read with care first, because a tumour that is responding can sometimes look bigger.

What is the next tablet after imatinib?

Sunitinib is the usual second tablet. Regorafenib follows it, then ripretinib. A rare gene change called PDGFRA D842V is treated with avapritinib instead.

Can one growing spot be treated without changing the drug?

Often yes. A single growing spot can be removed, burned with a needle or treated with focused radiation, while the same tablet continues. This keeps later drugs in reserve.

Is a higher imatinib dose worth trying?

It can help some people who grew on the usual dose and carry the common gene change. The gain is usually short, and it brings more side effects.

Can I stop the tablet if I feel well?

No. A GIST can regrow quickly when the drug is paused. Any break should be planned with your oncologist, including breaks for an operation.

Are the later drugs available in India?

Imatinib, sunitinib and regorafenib are available as generics. Ripretinib and avapritinib are costly and reached mostly through access programmes or trials.

Does the gene test need to be repeated?

It helps. A fresh sample from the growing spot shows what has changed. A blood test of tumour genes can do the same. Either one helps pick the next drug or trial.

Related pages

For the full picture of GIST and its treatment, start at the GIST treatment in Ahmedabad page. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

You have taken imatinib for a GIST, and now a scan says the tumour is growing again. That is a hard thing to hear, but it is not the end of the road. Several other tablets exist, and a single growing spot can often be dealt with on its own. This post explains what resistance means, what is tried in what order, and where surgery still helps. Dr Harsh Shah, a stomach cancer surgeon in Ahmedabad, reviews your scans and reports and plans the local treatment with your medical oncologist. Bring everything you have. You can call us or book by message. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.